The Indian Institute of Technology Madras is preparing to undertake mass production of red blood cells from stem cells to be used for transfusions, with clinical studies beginning in three years. The method uses low-cost materials and has produced more than enough cells for transfusion in developmental testing, researchers said.
Institute prepares for production of RBCs from stem cells
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan